» Articles » PMID: 29700084

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Overview
Journal Circ Res
Date 2018 Apr 28
PMID 29700084
Citations 781
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) are well known for their role in mediating both physiological and pathophysiological signal transduction. Enzymes and subcellular compartments that typically produce ROS are associated with metabolic regulation, and diseases associated with metabolic dysfunction may be influenced by changes in redox balance. In this review, we summarize the current literature surrounding ROS and their role in metabolic and inflammatory regulation, focusing on ROS signal transduction and its relationship to disease progression. In particular, we examine ROS production in compartments such as the cytoplasm, mitochondria, peroxisome, and endoplasmic reticulum and discuss how ROS influence metabolic processes such as proteasome function, autophagy, and general inflammatory signaling. We also summarize and highlight the role of ROS in the regulation metabolic/inflammatory diseases including atherosclerosis, diabetes mellitus, and stroke. In order to develop therapies that target oxidative signaling, it is vital to understand the balance ROS signaling plays in both physiology and pathophysiology, and how manipulation of this balance and the identity of the ROS may influence cellular and tissue homeostasis. An increased understanding of specific sources of ROS production and an appreciation for how ROS influence cellular metabolism may help guide us in the effort to treat cardiovascular diseases.

Citing Articles

Integrating biomarker clustering for improved diagnosis of interstitial cystitis/bladder pain syndrome: a review.

Chen Y, Kuo H Int Urol Nephrol. 2025; .

PMID: 40088357 DOI: 10.1007/s11255-025-04452-y.


Nitroxidative Stress, Cell-Signaling Pathways, and Manganese Porphyrins: Therapeutic Potential in Neuropathic Pain.

Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).

PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.


Extracellular vesicles lay the ground for neuronal plasticity by restoring mitochondrial function, cell metabolism and immune balance.

Hermann D, Wang C, Mohamud Yusuf A, Herz J, Doeppner T, Giebel B J Cereb Blood Flow Metab. 2025; :271678X251325039.

PMID: 40072028 PMC: 11904928. DOI: 10.1177/0271678X251325039.


Dopamine Toxicity Induces ROS-Dependent Death of Murine Neuroblastoma Cells: Impact on the Interactions of Cofilin With UCHL1 and MMP9.

Roy T, Banerjee R, Chatterjee A, Swarnakar S Neurochem Res. 2025; 50(2):111.

PMID: 40035962 DOI: 10.1007/s11064-025-04362-6.


Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect.

Kwon H, Jung Y, Jeon H, Han H Bioact Mater. 2025; 48:71-99.

PMID: 40034810 PMC: 11874232. DOI: 10.1016/j.bioactmat.2025.01.023.


References
1.
Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J . Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989; 320(14):915-24. DOI: 10.1056/NEJM198904063201407. View

2.
Semenza G . Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta. 2010; 1813(7):1263-8. PMC: 3010308. DOI: 10.1016/j.bbamcr.2010.08.006. View

3.
Furnkranz A, Leitinger N . Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships. Curr Pharm Des. 2004; 10(8):915-21. DOI: 10.2174/1381612043452929. View

4.
Zorov D, Filburn C, Klotz L, Zweier J, Sollott S . Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000; 192(7):1001-14. PMC: 2193314. DOI: 10.1084/jem.192.7.1001. View

5.
Steinhubl S . Why have antioxidants failed in clinical trials?. Am J Cardiol. 2008; 101(10A):14D-19D. DOI: 10.1016/j.amjcard.2008.02.003. View